Principal Securities’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
VCM
VPM
DAM
Principal Securities's RMD Position: Q1 2026 in Review
Principal Securities increased its ResMed (RMD) stake by 18% in Q1 2026, buying an estimated $44.1K and bringing the position to 1,172 shares worth $263K. The position accounts for ﹤0.01% of the portfolio, ranked #1268.
Principal Securities first reported a position in RMD in Q4 2023 and has held it in 10 quarters since. The position peaked at $288K in Q2 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.
- Principal Securities held 1,172 shares of ResMed worth $263K as of Q1 2026.
- Principal Securities bought 177 ResMed shares in Q1 2026, an estimated $44.1K.
- ResMed made up ﹤0.01% of Principal Securities's portfolio in Q1 2026, its #1268 holding.
- Principal Securities first reported a position in ResMed in Q4 2023 and has held it in 10 quarters since.
- Principal Securities's ResMed position peaked at $288K in Q2 2025.
- 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.
Based on Principal Securities's 13F filing for Q1 2026, filed 13 May 2026.